日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hungry for Knowledge: Octopamine Signaling Regulates Hunger-Enhanced Olfactory Learning

求知欲:章鱼胺信号调节饥饿增强的嗅觉学习

Zhao, Huijuan; Shi, Guiyuan; Qin, Ruixue; Sun, Yinghao; Guo, Wenbo; Shi, Ruixia; Peng, Minxian; Yang, Jingxuan; Zhao, Jianjian; Liu, Qiuhan; Xiao, Jun; Zhang, Ke; Liu, Qiang; Yang, Wenxing; Liu, He

Fermentation method outweighs geographic origin in shaping kefir's in vitro anti-obesity potential and probiotic properties

发酵方法比地理来源更能决定开菲尔的体外抗肥胖潜力和益生菌特性。

Ji, Qingyang; Qu, Hengxian; Li, Qiming; Gu, Ruixia

ICG-001 Provides Cardioprotection Against Doxorubicin-Induced Cardiotoxicity and Enhances Cancer Cytotoxicity

ICG-001 可保护心脏免受阿霉素诱导的心脏毒性,并增强癌细胞毒性

Wu, Binbin; Chen, Jack C H; Ma, Chloe H Y; Kwok, Maxwell; Chan, Valerie T; Sung, Chun C; Song, Yi; Zhang, Tao; Lam, Hin S; Meng, Fang; Liang, Yonghao; Tsoi, Chantelle; Deng, Ruixia; Tsui, Stephen K W; Leung, Kam T; Wang, Chi C; Chan, Godfrey C F; Boheler, Kenneth R; Chung, Kenny K K; Poon, Ellen N

Uptake of Nanoparticles as a Model System for Viruses under the Presence of Chloroquine

氯喹存在下纳米颗粒的摄取作为病毒的模型系统

Chen, Gan; Zhu, Dingcheng; Zhao, Yaofeng; Soh, Timothy K; Wang, Ruixia; Feliu, Neus; Parak, Wolfgang J

Case Report: Dual response to efgartigimod in myasthenia gravis and comorbid autoimmune disorders: a case series

病例报告:重症肌无力合并自身免疫性疾病患者对efgartigimod的双重反应:病例系列

Li, Yunjia; Yang, Yingying; Zhu, Ying; Zhu, Ruixia

How are kefir microbial communities and product characteristics maintained in industrial production?

工业生产中如何维持开菲尔微生物群落和产品特性?

Qingyang, Ji; Qiming, Li; Ruixia, Gu

A Prospective Clinical Trial of Efgartigimod for New-Onset Generalized Myasthenia Gravis

一项关于 Efgartigimod 治疗新发全身型重症肌无力的前瞻性临床试验

Ma, Chi; Shen, Jingyi; Zhu, Ying; Zhu, Ruixia

Elevated ANGPTL8 (Angiopoietin-Like Protein 8) Levels as a Novel Predictor of Atherosclerosis in Type 2 Diabetes: Beyond Lipid Metabolism

ANGPTL8(血管生成素样蛋白 8)水平升高作为 2 型糖尿病动脉粥样硬化的新型预测因子:超越脂质代谢

Ye, Huimin; Zhu, Qiang; Zong, Qunchuan; Luo, Shanyu; Ji, Zonghong; Zhang, Ruixia; Zou, Huajie

Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics

自体SVF疗法调节ALS中的神经炎症:I期试验证明其安全性和脑脊液生物标志物动态变化

Li, Ruixia; Wang, Lin; Bu, Wendi; Zhang, Xu; Li, Xiaojing; Li, Jing; Shen, Jiahui; Li, Jingwei; Cai, Zenglin

Effectiveness and Safety of Eculizumab in Highly Active AChR+gMG and Its Therapeutic Response in Different Subtypes of gMG

依库珠单抗治疗高活性AChR+gMG的有效性和安全性及其在不同亚型gMG中的治疗反应

Ma, Tianying; Liu, Yanan; Zhu, Ying; Gao, Yan; Wang, Xue; Liang, Yong; Wang, Benqiao; Zhu, Ruixia